Multinational Association of Supportive Care in Cancer

www.mascc.org

 

Where Are We Going With Biosimilars in Oncology? Data Based on the New Frontier in HER2+ Tumors - Trastuzumab

832 views
September 10, 2019
Comments 0
Login to view comments. Click here to Login